參考文獻 |
C. Han, and B. Wang, “Factors That Impact The Developability of Drug Candidates: An Overview,” Chapter 1 of Drug Delivery: Principles and Applications, edited by B. Wang, T. Siahaan, and R. Soltero, (John Wiley and Sons, Inc., New York, USA, pp. 1-5 2005)
K. Sweeny, “Technology Trends in Drug Discovery and Development: Implications for the Development of the Pharmaceutical Industry in Australia”, Draft Working Paper No. 3, Pharmaceutical Industry Project, CSES, Victoria University, Melbourne, pp. 1-29 (2002).
http://www.msd.com.hk/health_info/drug_education/e_ddp_introduction.html
H. Takahashi, R. Chen, H. Okamoto, and K. Danjo, “Acetaminophen Particle Design Using Chitosan and a Spray-Drying Technique,” Chem. Pharm. Bull., 53(1), 37-41 (2005).
J. Hecq, M. Dellers, D. Fanara, H. Vranckx, and K. Amighi, “Prepareation and Characterization of Nanocrystals for Solubility and Dissolution Rate Enhancement of Nifedipine,” Int. J. Pharm., 299(1-2), 167-177 (2005).
Q. R. Cau, Y. W. Choi, J. H. Cui, and B. J. Lee, “Formulation, Release Characteristics and Bioavailability of Novel Monolithic Hydroxypropylmethylcellulose Matrix Tablets Containing Acetaminophen,” J. Control. Release, 108(2-3), 351-361 (2005).
M. Brigell, C. J. Dong, S. Rosolen, and R. Tzekov, “An Overview of Drug Development with Special Emphasis on The Role of Visual Electrophysiological Testing,” Documenta Ophthalmologica, 110(1), 3-13 (2005).
D. Singhal, and W. Curatolo, “Drug Polymorphism and Dosage Form Design: a Practical Perspective,” Adv. Drug Deliv. Rev., 56(3), 335-347 (2004).
W. J. Genck, “Optimizing Crystallizer Scaleup: Understanding the Impact of Mixing on Crystallization Dynamics and Determine the Optimum Conditions for Scaleup,” CEP, 99(6), 36-44 (2003).
S. Kim, B. Lotz, M. Lindrud, K. Girard, T. Moore, K. Nagarajan, M. Alvarez, T. Lee, F. Nikfar, M. Davidovich, S. Srivastava, and S. Kiang, “Control of the Particle Properties of a Drug Substance by Crystallizatioin Engineering and the Effect on Drug Product Formulatioin,” Org. Process Res. Dev., 9(6), 894-901 (2005).
M. Charoenchaitrakool, F. Dehghani, and N. R. Foster, “Micronization by Rapid Expansioin of Supercritical Solutions to Enhance the Dissolution Rates of Poorly Water-Soluble Pharmaceuticals,” Ind. Eng. Chem. Res., 39(12), 4794-4802 (2000).
A. P. Tinke, K. Vanhoutte, R. Ed Maesschalck, S. Verheyen, and H. De Winter, “A New Approach in the Prediction of the Dissolution Behavior of Suspended Particles by Means of Their Particle Size Distribution,” J. Pharm. Bio. Ana., 39(5), 900-907 (2005).
T. Lee, and J. Lee, “Particle Attrition by Particle-Surface Friction in Dryers,” Pharm. Tech. North America, 27(5), 64-72 (2003).
A. Goldszal, and J. Bousquet, “Wet Agglomeration of Powders: From Physics Toward Process Optimization,” Pow. Tech., 117(3), 221-231 (2001).
W. Pietsch, “ Agglomeration in Industry: Occurrence and Applications,” Volume 1 (WILEY-VCH Verlag GmbH & Co. KGaA, Florida, USA, 2005) p. 3
P. Vonk, C. P. F. Guillaume, J. S. Ramaker, H. Vromans, and N. W. F. Kossen, “Growth Mechanisms of High-Shear Pelletisation,” Int. J. Pharm., 157(1), 93-102 (1997).
X. Pepin, S. Blanchon, and G. Couarraze, “Power Consumption Profiles in High-shear Wet Granulation. I: Liquid Distribution in Relation to Powder and Binder Properties,” J. Pharm. Sci., 90(3), 322-331 (2001).
T. Lee, C. S. Kuo, and Y. H. Chen, “Solubility, Polymorphism, Crystallinity, and Crystal Habit of Acetaminophen and Ibuprofen by Initial Solvent Screening,” Pharm. Tech., 30(10), 72-90 (2006).
M. Hariharan, L. D. Ganorkar, G. E. Amidon, A. Cavallo, P. Gatti, M. J. Hageman, I. Choo, J. L. Miller, and U. J. Shah, “Reducing the Time to Develop and Manufacture Formulations for First Oral Dose in Humans,” Pharm. Tech., 27(10), 68-84 (2003).
S. Byrn, K. Morris, and S. Comella, “Reducing Time to Market with A Science-Based Prodduct Management Strategy,” Pharm. Tech. outsourcing resources for the Pharmaceutical Industry, 46-65 (2005).
A. K. Bansal, and V. Koradia, “The Role of Reverse Engineering in the Development of generic Formulations,” Pharm. Tech., 29(8), 50-55 (2005).
A. M. Railkar, and J. B. Schwartz, “Evaluation and Comparison of a Moist Granulation Technique to Conventional Methods,” Drug Dev. Ind. Pharm., 26(8), 885-889 (2000).
S. L. Wang, S. Y. Lin, and Y. S. Wei, “Transformation of Metastable Forms of Acetaminophen Studied by Thermal Fourier Transform Infrared (FT-IR) Microspectroscopy,” Chem. Pharm. Bull., 50(2), 153-156 (2002).
H. A. Garekani, J. L. Ford, M. H. Rubinstein, and A. R. R. Siahboomi, “Formation and Compression Characteristics of Prismatic Polyhedral and Thin Plate-Like Crystals of Paracetamol,” Int. J. Pharm., 187(1), 77-89 (1999).
G. Nichols, and S. Frampton, “Physicochemical Characterization of the Orthorhombic Polymorph of Paracetamol Crystallized from Solution,” J. Pharm. Sci., 87(6), 684-693 (1998).
www.accelrys.com, “C2. Polymorph”,Cerius2 Datasheet
M. Szelagiewicz, C. Marcolli, S. Cianferani, A. P. Hard, A. Vit, A. Burkhard, M. von Raumer, U. Ch. Hofmeier, A. Zilian, E. Francotte, and R. Schenker, “In Situ Characterization of Polymorphic Forms The Potential of Raman Techniques,” J. Therm. Analy. Calor., 57(1), 23-43 (1999).
J.-L. Tsau, ”OTC Pain Medication Market: Current Status and Its Future Trends,” ITRI (2002).
The Annual Report of GlaxOSmithKline (GSK) from 2002 to 2006.
R. A. Granberg, and A. C. Rasmuson, “Solubility of Paracetamol in Pure Solvents,” J. Chem. Eng. Data., 44(6), 1391-1395 (1999).
B. A. Hendriksen, and D. J. W. Grant, “The Effect of Structurally Related Substances on the Nucleation Kinetics of Paracetamol (Acetaminophen),” J. Cry. Growth., 156(3), 252-260 (1995).
R. I. Ristic, S. Finnie, D. B. Sheen, and J. n. Sherwood, “Macro- and Micromorphology of Monoclinic Paracetamol Grown from Pure Aqueous Solution,” J. Phys. Chem. B, 105(38), 9057-9066 (2001).
C. A. Randall, S. Miyazaki, K. L. More, A. S. Bhalla, and R. E. Newnham, “Structural Property Relationships in Dielectrophoretically Assembled BaTiO3 Nanocomposites,” Mater. Lett., 15(1-2), 26-30 (1992).
J. C. Maxwell, A Treatise on Electricity and Magnetism (Clareendon Press, Oxford, England 1904), Vol. 1, p.440.
S. Torquato, “Random Heterogeneous Media: Microstructure and Improved Bounds on Effective Properties,” Appl. Mech. Rev., 44(2), 37- 73(1991).
G. Simpson, “The Dielectric Constants of a Ferroelectric Ceramic,” Ferroelectrics, 6, 283-288 (1974).
H. Looyenga, “Dielectric Constants of Heterogeneous Mixtures,” Physica, 31(3), 401- 406(1965).
Z. Hashin, and S. Shtrikman, “Conductivity of Polycrystals,” Phys. Rev., 130(1), 129-133 (1963).
R. Hilfiker, F. Blatter and M. von Raumer, “Relevance of Solid-state Properties for Pharmaceutical Products,” in R. Hilfiker, “Polymorphism in the Pharmaceutical Industry,” (WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2006) pp. 1-19.
T. L. Threlfall, “Analysis of Organic Polymorphs: A Review,” Analyst, 120(10), 2435-2460 (1995).
L. Yu, S. M. Reutzil and G. A. Stephenson, “Physical Characterization of Polymorphic Drugs: and Integrated Characterization Strategy,” PSTT, 1(3), 118-127 (1998).
D. J. W. Grant, “Theory and Origin of Polymorphism,” in H. G. Brittain, “Polymorphism in Pharmaceutical Solids,” (Marcel Dekker, Inc., New York, USA, 1999) pp. 1-33.
D. Giron, “Thermal Analysis and Calorimetric Methods in the Characterisation of Polymorphs and Solvates,” Thermochim. Acta, 248(2), 1-59 (1995).
H. G. Brittain, S. J. Bogdanowich, D. E. Bugay, J. De Vincentis, G. Lewen and A. W. Newman, “Physical Characterization of Pharmaceutical Solids,” Pharm. Res., 8(8), 963-973 (1991).
S. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg and G. Poochikian, “Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations,” Pharm. Res., 12(7), 945-954 (1995).
C. M. Sinko, “Granulation Characterization: Methods and Significance,” in D. M. Parikh, “Handbook of Pharmaceutical Granulation Technology,” (Marcel Dekker, Inc., New York, USA, 1997), pp. 419-434.
D. Giron, “Applications of Thermal Analysis and Coupled Techniques in Pharmaceutical Industry,” J. Therm. Anal. Calorim., 68(2), 335-357 (2001).
A. Weissberger and B. W. Rossiter, “Techniques of Chemistry, VolumeⅠ Physical Methods of Chemistry: Part Ⅴ Determination of Thermodynamic and Surface Properties,” (John Wiley and Sons, Inc., New York, USA, 1971), pp. 436-437.
D. A. Skoog, F. J. Holler and T. A. Nieman, “Principles of Instrumental Analysis 5th Ed.,” (Thomson Learning, Inc. Connecticut, USA, 1998), pp. 805-808.
L. R. Koller, “Ultravilet Radiation,” 2nd Ed., (John Wiley and Sons, Inc., New York, USA, 1965), pp.1-20.
M. J. Ayora Cañada, M. I. P. Reguera, A. Mo. Diaz, and L. F. C.Vallvey, “Solid-phase UV Spectroscopic Multisensor for the Simultaneous Determination of Caffeine, Dimenhydrinate and Acetaminophen by Using Partial Least Squares Multicalibration,” Talanta, 49(3), 691-701 (1999).
J. L. Koenig, S. Q. Wang and R. Bhargava, “FTIR images: A New Technique Produces Images Worth a Thousand Spectra,” Anal. Chem., 73(no13), 360A-369A (2001).
C. S. Colley, S. G. Kazarian, P. D. Weinberg and M. J. Lever, “Spectroscopic Imaging of Arteries and Atherosclerotic Plaques,” Biopolymers, 74(4), 328-335 (2004).
C. Petibois and G. Déléris, “Chemical Mapping of Tumor Progression by FT-IR Imaging: Towards Molecular Histopathology,” Trends Biotechnol., 24(10), 455-462 (2006).
O. S. Fleming, K. L. A. Chan and S. G. Kazarian, “FT-IR Imaging and Raman Microscopic Study of Poly(ethylene terephthalate) Film Processed with Supercritical CO2,” Vib. Spectrosc., 35(1-2), 3-7 (2004).
T. H. Lee and S. Y. Lin, “Microspectroscopic FT-IR Mapping System as a Tool to Assess Blend Homogeneity of Drug Excipient Mixtures,” Eur. J. Pharm. Sci., 23(2), 117-122 (2004).
K. L. A. Chan and S. G. Kazarian, “Fourier Transform Infrared Imaging for High-Throughput Analysis of Pharmaceutical Formulations,” J. Comb. Chem., 7(2), 185-189 (2005).
K. L. Andrew and S. G. Kazarian, “ATR-FTIR Spectroscopic Imaging with Expanded Field of View to Study Formulations and Dissolution,” Lab. Chip., 6(7), 864-870 (2006).
P. A. M. Smith, “Infrared Microspectroscopy Mapping Studies of Packaging Materials: Experiment Design and Data Profiling Considerations,” Vib. Spectrosc., 24(1), 47-62 (2000).
T. C. Kriss, V. M. Kriss, and M.Vesna, “History of the Operating Microscope: From Magnifying Glass to Microneurosurgery,” Neurosurgery, 42(4), 899-907 (1998).
I. Langmuir, “The Adsorption of Gases on Plane Surfaces of Glass, Mica and Platinum,” J. Am. Chem. Soc., 40(9), 1361-1403 (1918).
S. Brunauer, P. H. Emmett and E. Teller, “Adsorption of Gases in Multimolecular Layers,” J. Am. Chem. Soc., 60(2), 309-319 (1938).
P. A. Webb and C. Orr, “Analytical Methods in Fine Particle Technology,” (Micromeritics Instrument Corporation, Georgia, USA, 1997), pp.53-153.
Ibid., pp.193-199.
M. Viana, P. Jouannin, C. Pontier and D. Chulia, “About Pycnometric Density Measurements,” Talanta, 57(3), 583-593 (2002).
P. W. S. Heng and L. W. Chan, “Drug Substance and Excipient Characterization,” in D. M. Parikh, “Handbook of Pharmaceutical Granulation Technology,” (Marcel Dekker, Inc., New York, USA, 1997), pp. 32-34.
R. H. Perry and D. W. Green, “Perry’s Chemical Engineers’ Handbook,” 7th Ed. (The McGraw-Hill Companies, Inc., New York, USA, 1997), p. 20-9.
Ibid., pp. 19-18-19-23.
H. Giesche, “Mercury Porosimetry: A General (Practical) Overview,” PPSC, 23(1), 9-19 (2006).
K. Rübner and D. Hoffmann, “Characterization of Mineral Building Materials by Mercury-Intrusion Porosimetry,” PPSC, 23(1), 20-28 (2006).
M. J. Moura, P. J. Ferreira and M. M. Figueiredo, “Mercury Intrusion Porosimetry in Pulp and Paper Technology,” Powder Technol., 160(2), 61-66 (2005).
F. Porcheron and P. A. Monson, “Dynamic Aspects of Mercury Porosimetry: A Lattice Model Study,” Langmuir, 21(7), 3179-3186 (2005).
F. Porcheron, P. A. Monson and M. Thommes, “Molecular Modeling of Mercury Porosimetry,” Adsorption, 11(supplement 1), 325-329 (2005).
E. W. Washburn, “The Dynamics of Capillary Flow,” Phys. Rev., 17(3), 273-283 (1921).
R. Hilfiker, F. Blatter and M. von Raumer, “Relevance of Solid-state Properties for Pharmaceutical Products,” in R. Hilfiker, “Polymorphism in the Pharmaceutical Industry,” (WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2006) pp. 1-19.
T. L. Threlfall, “Analysis of Organic Polymorphs: A Review,” Analyst, 120(10), 2435-2460 (1995).
L. Yu, S. M. Reutzil and G. A. Stephenson, “Physical Characterization of Polymorphic Drugs: and Integrated Characterization Strategy,” PSTT, 1(3), 118-127 (1998).
D. J. W. Grant, “Theory and Origin of Polymorphism,” in H. G. Brittain, “Polymorphism in Pharmaceutical Solids,” (Marcel Dekker, Inc., New York, USA, 1999) pp. 1-33.
D. Giron, “Thermal Analysis and Calorimetric Methods in the Characterisation of Polymorphs and Solvates,” Thermochim. Acta, 248(2), 1-59 (1995).
H. G. Brittain, S. J. Bogdanowich, D. E. Bugay, J. De Vincentis, G. Lewen and A. W. Newman, “Physical Characterization of Pharmaceutical Solids,” Pharm. Res., 8(8), 963-973 (1991).
S. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg and G. Poochikian, “Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations,” Pharm. Res., 12(7), 945-954 (1995).
C. M. Sinko, “Granulation Characterization: Methods and Significance,” in D. M. Parikh, “Handbook of Pharmaceutical Granulation Technology,” (Marcel Dekker, Inc., New York, USA, 1997), pp. 419-434.
D. Giron, “Applications of Thermal Analysis and Coupled Techniques in Pharmaceutical Industry,” J. Therm. Anal. Calorim., 68(2), 335-357 (2001).
A. Weissberger and B. W. Rossiter, “Techniques of Chemistry, VolumeⅠ Physical Methods of Chemistry: Part Ⅴ Determination of Thermodynamic and Surface Properties,” (John Wiley and Sons, Inc., New York, USA, 1971), pp. 436-437.
D. A. Skoog, F. J. Holler and T. A. Nieman, “Principles of Instrumental Analysis 5th Ed.,” (Thomson Learning, Inc. Connecticut, USA, 1998), pp. 805-808.
L. R. Koller, “Ultravilet Radiation,” 2nd Ed., (John Wiley and Sons, Inc., New York, USA, 1965), pp.1-20.
M. J. Ayora Cañada, M. I. P. Reguera, A. Mo. Diaz, and L. F. C.Vallvey, “Solid-phase UV Spectroscopic Multisensor for the Simultaneous Determination of Caffeine, Dimenhydrinate and Acetaminophen by Using Partial Least Squares Multicalibration,” Talanta, 49(3), 691-701 (1999).
J. L. Koenig, S. Q. Wang and R. Bhargava, “FTIR images: A New Technique Produces Images Worth a Thousand Spectra,” Anal. Chem., 73(no13), 360A-369A (2001).
C. S. Colley, S. G. Kazarian, P. D. Weinberg and M. J. Lever, “Spectroscopic Imaging of Arteries and Atherosclerotic Plaques,” Biopolymers, 74(4), 328-335 (2004).
C. Petibois and G. Déléris, “Chemical Mapping of Tumor Progression by FT-IR Imaging: Towards Molecular Histopathology,” Trends Biotechnol., 24(10), 455-462 (2006).
O. S. Fleming, K. L. A. Chan and S. G. Kazarian, “FT-IR Imaging and Raman Microscopic Study of Poly(ethylene terephthalate) Film Processed with Supercritical CO2,” Vib. Spectrosc., 35(1-2), 3-7 (2004).
T. H. Lee and S. Y. Lin, “Microspectroscopic FT-IR Mapping System as a Tool to Assess Blend Homogeneity of Drug Excipient Mixtures,” Eur. J. Pharm. Sci., 23(2), 117-122 (2004).
K. L. A. Chan and S. G. Kazarian, “Fourier Transform Infrared Imaging for High-Throughput Analysis of Pharmaceutical Formulations,” J. Comb. Chem., 7(2), 185-189 (2005).
K. L. Andrew and S. G. Kazarian, “ATR-FTIR Spectroscopic Imaging with Expanded Field of View to Study Formulations and Dissolution,” Lab. Chip., 6(7), 864-870 (2006).
P. A. M. Smith, “Infrared Microspectroscopy Mapping Studies of Packaging Materials: Experiment Design and Data Profiling Considerations,” Vib. Spectrosc., 24(1), 47-62 (2000).
T. C. Kriss, V. M. Kriss, and M.Vesna, “History of the Operating Microscope: From Magnifying Glass to Microneurosurgery,” Neurosurgery, 42(4), 899-907 (1998).
I. Langmuir, “The Adsorption of Gases on Plane Surfaces of Glass, Mica and Platinum,” J. Am. Chem. Soc., 40(9), 1361-1403 (1918).
S. Brunauer, P. H. Emmett and E. Teller, “Adsorption of Gases in Multimolecular Layers,” J. Am. Chem. Soc., 60(2), 309-319 (1938).
P. A. Webb and C. Orr, “Analytical Methods in Fine Particle Technology,” (Micromeritics Instrument Corporation, Georgia, USA, 1997), pp.53-153.
Ibid., pp.193-199.
M. Viana, P. Jouannin, C. Pontier and D. Chulia, “About Pycnometric Density Measurements,” Talanta, 57(3), 583-593 (2002).
P. W. S. Heng and L. W. Chan, “Drug Substance and Excipient Characterization,” in D. M. Parikh, “Handbook of Pharmaceutical Granulation Technology,” (Marcel Dekker, Inc., New York, USA, 1997), pp. 32-34.
R. H. Perry and D. W. Green, “Perry’s Chemical Engineers’ Handbook,” 7th Ed. (The McGraw-Hill Companies, Inc., New York, USA, 1997), p. 20-9.
Ibid., pp. 19-18-19-23.
H. Giesche, “Mercury Porosimetry: A General (Practical) Overview,” PPSC, 23(1), 9-19 (2006).
K. Rübner and D. Hoffmann, “Characterization of Mineral Building Materials by Mercury-Intrusion Porosimetry,” PPSC, 23(1), 20-28 (2006).
M. J. Moura, P. J. Ferreira and M. M. Figueiredo, “Mercury Intrusion Porosimetry in Pulp and Paper Technology,” Powder Technol., 160(2), 61-66 (2005).
F. Porcheron and P. A. Monson, “Dynamic Aspects of Mercury Porosimetry: A Lattice Model Study,” Langmuir, 21(7), 3179-3186 (2005).
F. Porcheron, P. A. Monson and M. Thommes, “Molecular Modeling of Mercury Porosimetry,” Adsorption, 11(supplement 1), 325-329 (2005).
E. W. Washburn, “The Dynamics of Capillary Flow,” Phys. Rev., 17(3), 273-283 (1921).
S. Kim, B. Lotz, M. Lindrud, K. Girard, T. Moore, K. Nagarajan, M. Alvarez, T. Lee, F. Nikfar, M. Davidovich, S. Srivastava, and S. Kiang, “Control of the Particle Properties of a Drug Substance by Crystallizatioin Engineering and the Effect on Drug Product Formulatioin,” Org. Process Res. Dev., 9(6), 894-901 (2005).
M. Charoenchaitrakool, F. Dehghani, and N. R. Foster, “Micronization by Rapid Expansioin of Supercritical Solutions to Enhance the Dissolution Rates of Poorly Water-Soluble Pharmaceuticals,” Ind. Eng. Chem. Res., 39(12), 4794-4802 (2000).
A. P. Tinke, K. Vanhoutte, R. Ed Maesschalck, S. Verheyen, and H. De Winter, “A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution,” J. Pharm. Bio. Ana., 39(5), 900-907 (2005).
J. Hecq, M. Dellers, D. Fanara, H. Vranckx, and K. Amighi, “Prepareation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine,” Int. J. Pharm., 299(1-2), 167-177 (2005).
G. G. Liversidge, and K. C. Cundy, “Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs,” Int. J. Pharm., 125(1), 91-97 (1995).
B. Y. Shekunov, P. Chattopadhyay, J. Seitzinger, and R. Huff, “Nanoparticles of Poorly Water-Soluble Drugs Prepared by Supercritical Fluid Extraction of Emulsions,” Pharm. Res., 23(1), 196-204 (2006).
M. Mosharraf, and C. Nyström, “The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs,” Int. J. Pharm., 122(1-2), 35-47 (1995).
B. Albertini, C. Cavallari, N. Passerini, D. Voinovich, M. L. González-Rodríguez, L. Magarotto, and L. Rodriguez, “Characterizatioin and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer,” Eur. J. Pharm. Sci., 21(2-3), 295-303 (2004).
T. Lee, and J. Lee, “Particle Attrition by Particle-Surface Friction in Dryers,” Pharm. Tech. North America, 27(5), 64-72 (2003).
http://www.fda.gov/cvm/Guidance/guide176.pdf
C. A. Randall, S. Miyazaki, K. L. More, A. S. Bhalla, and R. E. Newnham, “Structural Property Relationships in Dielectrophoretically Assembled BaTiO3 Nanocomposites,” Mater. Lett., 15(1-2), 26-30 (1992).
J. C. Maxwell, A Treatise on Electricity, and Magnetism (Clareendon Press, Oxford, England 1904), Vol. 1, p.440.
S. Torquato, “Random Heterogeneous Media: Microstructure and Improved Bounds on Effective Properties,” Appl. Mech. Rev., 44(2), 37- 73(1991).
G. Simpson, “The Dielectric Constants of a Ferroelectric Ceramic,” Ferroelectrics, 6, 283-288 (1974).
H. Looyenga, “Dielectric Constants of Heterogeneous Mixtures,” Physica, 31(3), 401- 406(1965).
Z. Hashin, and S. Shtrikman, “Conductivity of Polycrystals,” Phys. Rev., 130(1), 129-133 (1963).
S. Byrn, K. Morris, and S. Comella, “Reducing Time to Market with A Science-Based Prodduct Management Strategy,” Pharm. Tech. outsourcing resources for the Pharmaceutical Industry, 46-65 (2005).
A. M. Railkar, and J. B. Schwartz, “Evaluation and Comparison of a Moist Granulation Technique to Conventional Methods,” Drug Dev. Ind. Pharm., 26(8), 885-889 (2000).
W. Sorasuchart, J. Wardrop, and J. W. Ayres, “Drug Release from Spray Layered and Coated Drug-Containing Beads: Effects of pH and Comparison of Different Dissolution Methods,” Drug Dev. Ind. Pharm., 25(10), 1093-1098 (1999).
S. A. Altaf, S. W. Hoag, and J. W. Ayres, “Bead Compacts. II. Evaluation of Rapidly Disintegrating Nonsegregating Compressed Bead Formulations,” Drug Dev. Ind. Pharm., 25(5), 635-642 (1999).
T. X. Viegas, R. U. Curatella, Lise L. Van Winkel, and G. Brinker, “Measurement of Intrinsic Drug Dissolution Rates Using Two Types of Apparatus,” Pharm. Tech., 25(6), 44-53 (2001).
N. K. Ebube, A. H. Hikal, C. M. Wyandt, D. C. Beer, L. G. Miller, and A. B. Jones, “Effect of Drug, Formulation and Process Variables on Granulation and Compaction Characteristics of Heterogeneous Matrices. Part 1: HPMC and HPC Systems,” Int. J. Pharm., 156(1), 49-57 (1997).
M. J. Habib, “Pharmaceutical Solid Dispersion Technology,” (Technomic Publishing Company, Inc., Pennsylvania, USA, 2001), pp. 12.
M. N. F. Oyewo, and M. S. Spring, “Studies on Paracetamol Crystals Produced by Growth in Aqueous solutionsm,” Int. J. Pharm., 112(1), 17-28 (1994). |